China's WuXi Biologics said on Monday it will sell its vaccine facility in Ireland to U.S. drugmaker Merck & Co for about $500 million. The Financial Times had reported in October that WuXi and WuXi ...
Nanovaccine achieved tumour inhibition rate of 89.3 per cent when tested on mice with aggressive form of the disease, study finds.
In a move to bolster global health cooperation, China has pledged its unwavering support for the World Health Organization ...
The quadrivalent HPV vaccine, developed by multinational pharmaceutical company Merck, was approved on Jan 8 for males on the Chinese mainland. The vaccine targets HPV types 6, 11, 16 and 18. The ...
Hepatitis E is a viral infection that is particularly dangerous for pregnant women and people with chronic illnesses, with a ...
"The Chinese poultry lineage may have experienced more vaccine-driven selection compared to other lineages," the researchers wrote.
Professor Paul Hunter from the University of East Anglia notes that almost every child contracts HMPV by five years of age, with reinfections occurring throughout life. “HMPV typically causes ...
As China continues to monitor an increase in cases of human metapneumovirus (HMPV), here's what you need to know about the ...
Philips CEO Roy Jakobs said he still expects subdued demand in China this year due to healthcare anti-corruption efforts by ...
China's diseases control authority said on Friday that it was piloting a monitoring system for pneumonia of unknown origin, with cases of some respiratory diseases expected to rise through the winter.